Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eric Simonson"'
Autor:
Leola N Chow, Petra Schreiner, Betina Y Y Ng, Bernard Lo, Michael R Hughes, R Wilder Scott, Vionarica Gusti, Samantha Lecour, Eric Simonson, Irina Manisali, Ingrid Barta, Kelly M McNagny, Jason Crawford, Murray Webb, T Michael Underhill
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151765 (2016)
Modulation of chemokine CXCL12 and its receptor CXCR4 has been implicated in attenuation of bleomycin (BLM)-induced pulmonary fibrosis and carbon tetrachloride (CCl4)-induced hepatic injury. In pulmonary fibrosis, published reports suggest that colla
Externí odkaz:
https://doaj.org/article/10e4ffcab880464593d2cf2468162c91
Autor:
Eric Simonson
Publikováno v:
Music in the Apocalyptic Mode ISBN: 9789004533011
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb28fe04ccc8c5cb6e1892961aedb00
https://doi.org/10.1163/9789004537996_011
https://doi.org/10.1163/9789004537996_011
Autor:
Rawad Farhat, Julian Aiken, Ninoschka C. D'Souza, Daniel Appadurai, Grayson Hull, Eric Simonson, Richard T. Liggins, Michael C. Riddell, Owen Chan
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 24(5)
To evaluate the pharmacokinetics and efficacy of a novel somatostatin receptor 2 antagonist, ZT-01, to stimulate glucagon release in rats with type 1 diabetes (T1D).The pharmacokinetics of ZT-01 and PRL-2903 were assessed following intraperitoneal or
Autor:
Matthew L. Statz, Eric Simonson, Richard Liggins, Jeff S. J. Yoon, Vionarica Gusti, Nathan J. White, Christian J. Kastrup, Amir Kazerooni, Michael M. Lee, James R. Baylis, Massimo Cau, Xu Wang, Alexander E. St. John
Publikováno v:
Journal of Thrombosis and Haemostasis. 17:1645-1654
Background Endogenous fibrinolytic activation contributes to coagulopathy and mortality after trauma. Administering tranexamic acid (TXA), an antifibrinolytic agent, is one strategy to reduce bleeding; however, it must be given soon after injury to b
Autor:
Julian Aiken, Michael C. Riddell, Richard Liggins, Eric Simonson, Rawad Farhat, Owen Chan, Ninoschka C. D’Souza
Publikováno v:
Diabetes. 69
Iatrogenic hypoglycemia remains one of the most serious risks for people with type 1 diabetes (T1D) undergoing intensive insulin therapy. Development of counterregulatory failure, occurring in the early stages of diabetes, highlighted by loss of the
Publikováno v:
Diabetes. 69
Restoration of the lost glucagon response to hypoglycemia may be an effective means to prevent the onset of hypoglycemia in patients with type 1 diabetes (T1D). Elevation of the inhibitory hormone somatostatin in T1D may act on alpha cells, via the s
Autor:
Matthew L. Statz, Esther B. Lim, Richard Liggins, Eric Simonson, James R. Baylis, Nathan J. White, Diana Chien, Christian J. Kastrup, Susan A. Stern, Xu Wang, Alexander E. St. John
Publikováno v:
Shock. 46:123-128
Hemorrhage is the leading cause of preventable death in trauma, and hemorrhage from noncompressible junctional anatomic sites is particularly difficult to control. The current standard is QuikClot Combat Gauze packing, which requires 3 min of compres
Autor:
Jason Crawford, Ingrid Barta, Murray S. Webb, R. Wilder Scott, Eric Simonson, Kelly M. McNagny, Leola N. Chow, Michael R. Hughes, Irina Manisali, Vionarica Gusti, T. Michael Underhill, Petra Schreiner, Betina Y. Y. Ng, Samantha Lecour, Bernard C. Lo
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151765 (2016)
PLoS ONE
PLoS ONE
Modulation of chemokine CXCL12 and its receptor CXCR4 has been implicated in attenuation of bleomycin (BLM)-induced pulmonary fibrosis and carbon tetrachloride (CCl4)-induced hepatic injury. In pulmonary fibrosis, published reports suggest that colla
Autor:
Jerrie Lynn Morrison, Gerald W. Zamponi, Frank Porreca, Todd W. Vanderah, Elizabeth Tringham, Lester A. Mitscher, Eric Simonson, Terrance P. Snutch, Hossein Pajouhesh, Hassan Pajouhesh, Francesco Belardetti, Zhong Ping Feng, Lingyun Zhang, Yanbing Ding
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(4)
A novel series of compounds derived from the previously reported N-type calcium channel blocker NP118809 (1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one) is described. Extensive SAR studies resulted in compounds with IC(50) values in the ran